- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Kelly Rogers
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Melissa Call
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Shalin Naik
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor Daniel Gray
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jeanne Tie
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marnie Blewitt
- Professor Matthew Ritchie
- Professor Melanie Bahlo
- Professor Melissa Davis
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Czabotar
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sandra Nicholson
- Professor Sant-Rayn Pasricha
- Professor Seth Masters
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A multi-pronged approach to targeting myeloproliferative neoplasms
- A new paradigm of machine learning-based structural variant detection
- A whole lot of junk or a treasure trove of discovery?
- Advanced imaging interrogation of pathogen induced NETosis
- Analysing the metabolic interactions in brain cancer
- Atopic dermatitis causes and treatments
- Boosting the efficacy of immunotherapy in lung cancer
- Building a cell history recorder using synthetic biology for longitudinal patient monitoring
- Characterisation of malaria parasite proteins exported into infected liver cells
- Deciphering the heterogeneity of the tissue microenvironment by multiplexed 3D imaging
- Defining the mechanisms of thymic involution and regeneration
- Delineating the molecular and cellular origins of liver cancer to identify therapeutic targets
- Developing computational methods for spatial transcriptomics data
- Developing drugs to block malaria transmission
- Developing models for prevention of hereditary ovarian cancer
- Developing statistical frameworks for analysing next generation sequencing data
- Development and mechanism of action of novel antimalarials
- Development of novel RNA sequencing protocols for gene expression analysis
- Discoveries in red blood cell production and function
- Discovering epigenetic silencing mechanisms in female stem cells
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Dissecting mechanisms of cytokine signalling
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- Epigenetic biomarkers of tuberculosis infection
- Epigenetics – genome wide multiplexed single-cell CUT&Tag assay development
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Exploiting the cell death pathway to fight Schistosomiasis
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- How do nutrition interventions and interruption of malaria infection influence development of immunity in sub-Saharan African children?
- Human lung protective immunity to tuberculosis
- Improving therapy in glioblastoma multiforme by activating complimentary programmed cell death pathways
- Innovating novel diagnostic tools for infectious disease control
- Integrative analysis of single cell RNAseq and ATAC-seq data
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigation of a novel cell death protein
- Malaria: going bananas for sex
- Mapping spatial variation in gene and transcript expression across tissues
- Mechanisms of Wnt secretion and transport
- Multi-modal computational investigation of single-cell communication in metastatic cancer
- Nanoparticle delivery of antibody mRNA into cells to treat liver diseases
- Naturally acquired immune response to malaria parasites
- Organoid-based discovery of new drug combinations for bowel cancer
- Organoid-based precision medicine approaches for oral cancer
- Removal of tissue contaminations from RNA-seq data
- Reversing antimalarial resistance in human malaria parasites
- Role of glycosylation in malaria parasite infection of liver cells, red blood cells and mosquitoes
- Screening for novel genetic causes of primary immunodeficiency
- Single-cell ATAC CRISPR screening – Illuminate chromatin accessibility changes in genome wide CRISPR screens
- Spatial single-cell CRISPR screening – All in one screen: Where? Who? What?
- Statistical analysis of single-cell multi-omics data
- Structural and functional analysis of epigenetic multi-protein complexes in genome regulation
- Structural basing for Wnt acylation
- Structure, dynamics and impact of extra-chromosomal DNA in cancer
- Targeted deletion of disease-causing T cells
- Targeting cell death pathways in tissue Tregs to treat inflammatory diseases
- The cellular and molecular calculation of life and death in lymphocyte regulation
- The role of hypoxia in cell death and inflammation
- The role of ribosylation in co-ordinating cell death and inflammation
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding cellular-cross talk within a tumour microenvironment
- Understanding the genetics of neutrophil maturation
- Understanding the roles of E3 ubiquitin ligases in health and disease
- Unveiling the heterogeneity of small cell lung cancer
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to understand malaria invasion and transmission
- Using structural biology to understand programmed cell death
- Validation and application of serological markers of previous exposure to malaria
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Ashley Weir
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jasmine Rou
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Krishneel Prasa
- Lilly Backshell
- Malvika Kharbanda
- Megan Kent
- Naomi Jones
- Pailene Lim
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Sophie Collard
- Wayne Cawthorne
- Wil Lehmann
- Yanxiang Meng
- Zhong Yan Gan
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A generous vision for impactful medical research
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Philanthropy through the power of sisterhood
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- Donors
- WEHI.TV
Carrie’s Beanies 4 Brain Cancer and WEHI launch The Brain Cancer Centre
25 October 2021
and her team will use cutting-edge technology to
better apply immunotherapy to brain cancers.
Carrie’s Beanies 4 Brain Cancer and WEHI have partnered to establish The Brain Cancer Centre, announced today.
The Brain Cancer Centre will bring together Australia’s brightest medical research minds to end brain cancer as a terminal illness, and will be led by WEHI.
The Centre has been established with an initial commitment of $40 million, which includes a foundational gift from Carrie’s Beanies 4 Brain Cancer, made possible thanks to the generosity of its donors and supporters. The remaining funding includes a $16 million commitment from the Victorian Government and additional support from WEHI and partner organisations.
At a glance
- Carrie’s Beanies 4 Brain Cancer and WEHI have partnered to establish The Brain Cancer Centre, bringing together our brightest medical research minds to end brain cancer as a terminal illness.
- The Brain Cancer Centre’s vision is to end brain cancer as a terminal illness and give real hope to patients and their families.
- The Victorian Government will provide funding of $16 million to support the Brain-POP initiative, a patient-focused brain cancer program.
United effort to end brain cancer
The Brain Cancer Centre is the culmination of a long-term collaboration between Carrie’s Beanies 4 Brain Cancer and WEHI and is founded on a shared vision to end brain cancer as a terminal illness.
It will bring together the brightest brain cancer researchers from partner organisations in the Melbourne Biomedical Precinct and around Australia to collaborate and translate their research discoveries into new treatments.
WEHI Director and Head of The Brain Cancer Centre, Professor Doug Hilton AO, said improving outcomes for children and adults with brain cancer required a sustained, coordinated and long-term commitment to collaborative research and discovery.
“The Brain Cancer Centre will provide the increased momentum and collaboration needed to take our vision of ending brain cancer as a terminal illness and make it a reality.
"It will enable us to attract the best new talent and build our local capabilities in brain cancer research and translation, and to develop new treatments that will be more effective with fewer side effects, improving quality of life," he said.
“By combining the scientific knowledge and clinical expertise of Australia’s top brain cancer researchers, and training the next generation of leading brain cancer researchers, the Centre will have the best chance of making the long-term and transformative discoveries that will have a real impact on brain cancer patients, now and in the future."
Shared vision comes to life
When Carrie’s Beanies 4 Brain Cancer founder, Carrie Bickmore OAM, started her fundraising mission in 2015, her vision was to raise awareness and much needed funding for vital brain cancer research. Brain cancer survival rates have barely changed in 30 years and the only way to impact those devastating statistics is through more funding for vital research.
The Brain Cancer Centre, founded by Carrie’s Beanies 4 Brain Cancer and established in partnership with WEHI, is the culmination of a shared vision to end brain cancer as a terminal illness.
Ms Bickmore said she was excited to see The Brain Cancer Centre brought to life after years of fundraising efforts.
“Establishing The Brain Cancer Centre is only possible because of the generosity of Australians who supported Carrie’s Beanies 4 Brain Cancer and bought a beanie, held a fundraiser or donated.
“We want to see a day come when no family has to lose someone they love to brain cancer. We want to make sure that every Australian diagnosed with brain cancer will have access to the best treatments and be given real hope for a positive outcome.
“I truly believe that together we can achieve that,” she said.
Improving patient outcomes
The Victorian Government has committed $16 million in funding to support Brain-POP (brain perioperative clinical trial program). The clinical trial program will deliver innovative, perioperative clinical trials with paediatric, adolescent and adult patients that will help researchers to create a holistic picture of brain cancer treatment that has so far been missing from research.
Minister for Innovation, Medical Research and the Digital Economy, The Hon. Jaala Pulford MP, said the Victorian Government investment would be used to run the trial over the next four years and deliver a globally unique program that is set to save the lives of more children, adolescents and adults with primary brain cancer and brain metastases.
“We urgently need to find more effective and curative treatments for brain cancers. As a global leader in cancer care and medical research, Victoria is perfectly positioned to lead this ground-breaking work," she said.
"We’re backing The Brain Cancer Centre and our extraordinary medical researchers to continue their amazing work in their fight against brain cancer."
The Brain Cancer Centre will drive new collaborations, push forward with novel treatments, develop better predictors of how brain cancer develops and ultimately accelerate more effective and targeted treatments for patients.
The Brain Cancer Centre includes research collaborations between WEHI, Peter MacCallum Cancer Centre, The Royal Melbourne Hospital, The Royal Children’s Hospital, Murdoch Children’s Research Institute, Monash University, the University of Queensland and the Victorian Comprehensive Cancer Centre. The teams will concentrate their efforts on new brain cancer discoveries, diagnostics and treatments.
The Brain Cancer Centre will continue to drive outcomes in partnership with the Australian Brain Cancer Mission and Cancer Australia, and the other members of The Mission, who share our desire to achieve better outcomes for those diagnosed with brain cancer in the future.
Media inquiries
M: +61 475 751 811
E: communityrelations@wehi.edu.au
Super Content:
Carrie’s Beanies 4 Brain Cancer and WEHI have partnered to establish The Brain Cancer Centre.
The Brain Cancer Centre will bring together Australia’s brightest medical research minds to end brain cancer as a terminal illness.
A novel approach to immunotherapy design could pave the way for new treatments for people with an aggressive form of brain cancer called glioblastoma.
Funding from Carrie Bickmore’s Beanies 4 Brain Cancer Foundation is helping to advance immunotherapy treatments
Want to be informed of our most exciting discoveries? Subscribe to our quarterly newsletter, Illuminate.